AstraZeneca’s Imfinzi, Lynparza combo approved in EU for certain endometrial cancer patients

Two of AstraZeneca’s top cancer treatments have been approved in combination to treat a subgroup of endometrial cancer patients in the European Union, the drugmaker …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Policymakers Must Balance Innovation With Patient Safety for AI in Healthcare

When it comes to artificial intelligence (AI) in healthcare, policymakers must balance innovation with potential harms to patients and healthcare workers, lawmakers and witnesses said

November 10, 2023

Revenue growth in all regions (+8 %) and adjusted earnings improvement (EBITDA +21 %) – Biotech Investments

EQS-News: aap Implantate AG / Key word(s): Quarter Results/Half Year Report Q2/2023: Revenue growth in all regions (+8 %) and adjusted earnings improvement (EBITDA +21

August 15, 2023

COMPASS Pathways to participate in upcoming September investor conferences – Psychedelic Alpha

LONDON, Aug. 29, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental

August 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.